1. Home
  2. TRTX vs DRUG Comparison

TRTX vs DRUG Comparison

Compare TRTX & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TPG RE Finance Trust Inc.

TRTX

TPG RE Finance Trust Inc.

N/A

Current Price

$6.36

Market Cap

660.2M

Sector

Real Estate

ML Signal

N/A

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

N/A

Current Price

$49.35

Market Cap

778.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TRTX
DRUG
Founded
2014
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Pharmaceuticals and Biotechnology
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
660.2M
778.4M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
TRTX
DRUG
Price
$6.36
$49.35
Analyst Decision
Buy
Strong Buy
Analyst Count
6
8
Target Price
$9.88
★ $166.78
AVG Volume (30 Days)
★ 837.3K
68.0K
Earning Date
10-27-2026
08-17-2026
Dividend Yield
★ 15.34%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.19
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$8.53
N/A
P/E Ratio
$33.58
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.19
$48.94
52 Week High
$9.37
$123.75

Technical Indicators

Market Signals
Indicator
TRTX
DRUG
Relative Strength Index (RSI) 12.02 26.75
Support Level N/A N/A
Resistance Level $8.74 $78.35
Average True Range (ATR) 0.17 2.85
MACD -0.08 -0.69
Stochastic Oscillator 9.16 14.04

Price Performance

Historical Comparison
TRTX
DRUG

About TRTX TPG RE Finance Trust Inc.

TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating-rate first mortgage loans that are secured by high-quality commercial real estate properties undergoing some form of transition and value creation.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: